How Digital Censorship is Hurting Women’s Health Startups—And What Investors Need to Know

Imagine launching a groundbreaking women’s health startup—one that finally addresses a long-ignored medical need.

You have the science, the team, and the funding. You go to market, only to find your ads repeatedly rejected, your content shadowbanned, and your community struggling to find you online. Not because your product is ineffective, but because an algorithm has decided that words like “menopause,” “breast health,” or “fertility” are inappropriate.

This isn’t a hypothetical. This is happening. Right now.

To dozens of early-stage women’s health companies.

And it’s costing them growth, funding, and ultimately, the ability to get life-changing products into the hands of women who need them most.